Leucovorin Calcium Market Analysis

  • Report ID: 4020
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Leucovorin Calcium Market Analysis

End-user (Hospital, Retail Pharmacies, Specialty Clinics)

The global leucovorin calcium market is segmented and analyzed for demand and supply by end users into hospitals, retail pharmacies, specialty clinics, and others. Out of these, the hospital segment is anticipated to hold the largest market share by the end of 2037. The expansion of the healthcare system and the fact that the drug is not widely accessible and must be purchased with a prescription from a doctor both contribute to the market's growth. Also, the presence of growing cases of cancer and critical blood cell disorder raises the demand for the hospital segment globally. For instance, 1.25 million new instances of blood cancer, or about 6% of all cancer cases, are recorded annually. Leucovorin calcium is typically used for the treatments such as Hodgkin's lymphoma, ovarian cancer, colorectal cancer, and brain tumors. Leucovorin calcium has been used more frequently in hospital pharmacies as a result of its expanding potential for treating various malignancies, particularly colon cancer.

Route of Administration (Oral, Injectable)

The global leucovorin calcium market is segmented and analyzed for demand and supply by route of administration into oral, injectable, and others. Out of these, the injectable segment is anticipated to hold the largest market share by the end of 2037. Leucovorin is a medicine that consists of an active ingredient named leucovorin. It appears in injection form for application by intravenous infusion, intramuscularly into the under the skin of the stomach, muscle, or arm. The injection is found at API with sodium chloride, water for injection, and sodium hydroxide, or hydrochloric acid as a buffer.

Our in-depth analysis of the global market includes the following segments:

         By Route of Administration

  • Oral
  • Injectable
  • Others

         By End User

  • Hospital
  • Retail Pharmacies
  • Specialty Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4020
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of leucovorin calcium is estimated at USD 34.38 million.

The leucovorin calcium market size was over USD 26.98 million in 2024 and is poised to exceed USD 187.87 million by 2037, witnessing over 16.1% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of colorectal cancer and rising cancer awareness will propel the market growth.

North America industry is set to hold largest revenue share by 2037, owing to presence of major pharmaceutical companies in the region.

The major players in the market are Exelixis Inc., PromoCell GmbH, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample